The Effect of Liquid Meal Replacements on Cardiometabolic Risk Factors in Overweight/Obese Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Open accessPublished version of a preprint
The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The evidence for liquid meal replacements in diabetes has not been summarized. Our objective was to synthesize the evidence of the effect of liquid meal replacements on cardiometabolic risk factors in overweight/obese individuals with type 2 diabetes. RESEARCH DESIGN AND METHODS: Data sources included MEDLINE, EMBASE, and the Cochrane Library through 10 December 2018. We included randomized trials of ≥2 weeks assessing the effect of liquid meal replacements in weight loss diets compared with traditional weight loss diets on cardiometabolic risk factors in overweight/obese subjects with type 2 diabetes. Two independent reviewers extracted relevant data and assessed risk of bias. Data were pooled using the inverse variance method. The overall certainty of the evidence was evaluated using GRADE (Grading of Recommendations Assessment, Development and Evaluation). RESULTS: Nine trial comparisons (N = 961 [median follow-up 24 weeks]) met eligibility criteria. Mean differences were for body weight −2.37 kg (95% CI −3.30 to −1.44), BMI −0.87 kg/m2 (−1.31 to −0.42), body fat −1.66% (−2.17 to −1.15), waist circumference −2.24 cm (−3.72 to −0.77), HbA1c −0.43% (−0.66 to −0.19) (−4.7 mmol/mol [−7.2 to −2.1]), fasting glucose −0.63 mmol/L (−0.99 to −0.27), fasting insulin −11.83 pmol/L (−23.11 to −0.54), systolic blood pressure −4.97mmHg (−7.32 to −2.62), and diastolic blood pressure −1.98 mmHg (−3.05 to −0.91). There was no effect on blood lipids. The overall certainty of the evidence was low to moderate owing to imprecision and/or inconsistency. CONCLUSIONS: Liquid meal replacements in weight loss diets lead to modest reductions in body weight, BMI, and systolic blood pressure, and reductions of marginal clinical significance in body fat, waist circumference, HbA1c, fasting glucose, fasting insulin, and diastolic blood pressure. More high-quality trials are needed to improve the certainty in our estimates.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite these recommendations, less intense exercise and walking programs can reduce risk of DM.846,855”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [855]
In the citing paper
“For example, studies have consistently shown that a walking program is associated with reductions in DM incidence,855 and low-intensity exercise can improve glycemic control in T2D.939,940”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [855]
In the citing paper
“Only seven meta-analyses (LCDs, n = 5 [37–40, 41]; liquid meal replacement, n = 1 [42]; very low energy diet (VLED), n = 1 [43]) were assessed as high quality.”
In the citing paper
“One high-quality meta-analysis [42] of nine RCTs including 931 participants reported that replacing one to three main meals daily (replacing 13–47% of total energy) produced significantly greater weight loss than low-energy diets over 12–52 weeks (−2.4 kg; 95% CI −3.3, −1.4; I2 = 84%, p < 0.001; GRADE moderate certainty of evidence).”
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099 · cited 1×
“pected, Duval and Tweedie nonparametric “trim and fill” analyses were applied to assess the effect of the imputed “missing” studies (14).”
MethodTuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
The Look AHEAD Research Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212914 · Cited by 2,908
Meta-analyses involving cross-over trials: methodological issues
Elbourne, D. R., Altman, D. G., Higgins, J. P., Curtin, F., Worthington, H. V., & Vail, A. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.140 · Cited by 2,305
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095
Beneficial health effects of modest weight loss.
Dj, G. (1992) · PubMed · Cited by 1,263
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Evidence-based European recommendations for the dietary management of diabetes
The Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD), Aas, A.-M., Axelsen, M., Churuangsuk, C., Hermansen, K., Kendall, C. W. C., Kahleova, H., Khan, T., Lean, M. E. J., Mann, J. I., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05894-8 · Cited by 262
“Recommendations for food-based approaches are supported by systematic reviews and meta-analyses commissioned by the DNSG that included broader populations inclusive of those with diabetes or at risk for diabetes [70, 129, 130] as well as broader evidence on these foods and relevant outcomes [85, 131–136].”
InfluentialSelf-citationDietary interventions for obesity: clinical and mechanistic findings.
Chao, A. M., Quigley, K. M., & Wadden, T. A. (2021) · Journal of Clinical Investigation · doi:10.1172/jci140065 · Cited by 257
Churuangsuk, C., Hall, J., Reynolds, A., Griffin, S. J., Combet, E., & Lean, M. E. J. (2022) · Diabetologia · doi:10.1007/s00125-021-05577-2 · Cited by 204
“Only seven meta-analyses (LCDs, n = 5 [37–40, 41]; liquid meal replacement, n = 1 [42]; very low energy diet (VLED), n = 1 [43]) were assessed as high quality.”
BackgroundInfluentialSievenpiper, J. L. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuz082 · Cited by 144
Self-citationNadolsky, K., Garvey, W. T., Agarwal, M., Bonnecaze, A., Burguera, B., Chaplin, M. D., Griebeler, M. L., Harris, S. R., Schellinger, J. N., Simonetti, J., et al. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.07.017 · Cited by 141
Hassapidou, M., Vlassopoulos, A., Kalliostra, M., Govers, E., Mulrooney, H., Ells, L., Salas, X. R., Muscogiuri, G., Darleska, T. H., Busetto, L., et al. (2023) · Obesity Facts · doi:10.1159/000528083 · Cited by 121
Kahleova, H., Salas-Salvadó, J., Rahelić, D., Kendall, C. W., Rembert, E., & Sievenpiper, J. L. (2019) · Nutrients · doi:10.3390/nu11092209 · Cited by 114
“Figure 1 shows the process used to select the papers for the systematic reviews and meta-analyses (SRMAs) of the Mediterranean dietary pattern [30,31], vegetarian dietary pattern [32,33], liquid meal replacement dietary pattern [34], Nordic dietary pattern [35], Portfolio dietary pattern [36], and Dietary Approaches t…”
BackgroundMethodSelf-citationMessina, M. J., Sievenpiper, J. L., Williamson, P., Kiel, J., & Erdman, J. W. (2022) · Advances in Nutrition · doi:10.1093/advances/nmac026 · Cited by 127
Self-citationBeyond Body Weight-Loss: Dietary Strategies Targeting Intrahepatic Fat in NAFLD
Worm, N. (2020) · Nutrients · doi:10.3390/nu12051316 · Cited by 83
Alexander, L., Christensen, S. M., Richardson, L., Ingersoll, A. B., Burridge, K., Golden, A., Karjoo, S., Cortez, D., Shelver, M., & Bays, H. E. (2022) · Obesity Pillars · doi:10.1016/j.obpill.2021.100005 · Cited by 61
“VLCDs may reduce fasting glucose, insulin, triglyceride, low-density lipoprotein cholesterol levels, may reduce blood pressure, and may modestly increase high-density lipoprotein cholesterol levels [51,52].”
BackgroundVitale, R., & Kim, Y. (2020) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2020.0048 · Cited by 43
“69 Three isocaloric diets produced the greatest loss in waist circumference potentially because of the shorter study duration and a higher calorie restriction compared with the TRF study.”
Szczerba, E., Barbaresko, J., Schiemann, T., Stahl‐Pehe, A., Schwingshackl, L., & Schlesinger, S. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2023-000664 · Cited by 65
Xu, B., Fu, J., Qiao, Y., Cao, J., Deehan, E. C., Li, Z., Jin, M., Wang, X., & Wang, Y. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa435 · Cited by 41
Kang, S., Kang, S. M., Choi, J. H., Ko, S., Koo, B. K., Kwon, H.-S., Kim, M. K., Kim, S. Y., Kim, S., Kim, Y., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0469 · Cited by 83
Overall assessment of fermented feed for pigs: a series of meta-analyses
Xu, B., Zhu, L., Fu, J., Li, Z., Wang, Y., & Jin, M. (2019) · Journal of Animal Science · doi:10.1093/jas/skz350 · Cited by 41
Impact of Visceral and Hepatic Fat on Cardiometabolic Health
Khawaja, T., Nied, M., Wilgor, A., & Neeland, I. J. (2024) · Current Cardiology Reports · doi:10.1007/s11886-024-02127-1 · Cited by 49
“…meal replacement nutritional offerings (as either part of total diet replacement program or taken daily in place of snacks/ meals) have led to increased weight loss as compared to programs without meal replacement options with significantly reduced cardiovascular risk factors [43, 44].”
BackgroundMustad, V. A., Hegazi, R. A. F., Hustead, D. S., Budiman, E. S., Rueda, R., Maki, K. C., Powers, M. A., Mechanick, J. I., Bergenstal, R. M., & Hamdy, O. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001258 · Cited by 30
Sievenpiper, J. L., Ard, J. D., Blüher, M., Chen, W., Dixon, J. B., Fitch, A., Gigliotti, L., Khunti, K., Lecube, A., Lean, M., et al. (2025) · Obesity Pillars · doi:10.1016/j.obpill.2025.100228 · Cited by 56
“…to weight loss when used as total diet replacement (i.e., replacing all meals) for up to 12 weeks or partial diet replacement (i.e., replacing 1 – 2 meals/day); as meal replacements they can support weight maintenance but may require additional fibre or micronutrient supplementation [131 – 134].”
Self-citationShireen, A., & Wright, A. J. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2023.9250003 · Cited by 23
“Considering this and the positive impact of plant-protein-based meal replacements on weight management seen in other clinical trials [116,117], Messina and colleagues concluded that PBMA (specifically based on soy) are not innately obesogenic [31].”
Nutritional Strategies for Prevention and Management of Diabetes: Consensus and Uncertainties
Wylie‐Rosett, J., & Hu, F. B. (2019) · Diabetes Care · doi:10.2337/dci19-0009 · Cited by 16
“(5) analyzed nine weight loss RCTs that were designed to evaluate the use of liquid meal replacements among patients with type 2 diabetes.”
BackgroundEfficacy and Safety of Meal Replacement in Patients With Type 2 Diabetes
Ye, W., Xu, L., Ye, Y., Zeng, F., Lu, X., Li, Y., & Liu, L. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad273 · Cited by 17
Evidenz in der Ernährungstherapie des Diabetes mellitus
Hauner, H. (2021) · Der Diabetologe · doi:10.1007/s11428-021-00784-2 · Cited by 17
Noronha, J. C., Nishi, S. K., Khan, T. A., Mejía, S. B., Kendall, C. W. C., Kahleová, H., Rahelić, D., Salas‐Salvadó, J., Leiter, L. A., Lean, M. E. J., et al. (2024) · Obesity Reviews · doi:10.1111/obr.13751 · Cited by 16
“7 However, the reductions in body fat, waist circumference, HbA 1c , fasting glucose, fasting insulin, and diastolic blood pressure were of marginal clinical significance, and there was no effect of meal replacements on blood lipids.”
BackgroundSelf-citationArd, J. D., Neeland, I. J., Rothberg, A. E., Chilton, R. J., de Luis, D., Cohen, S. S., & Johansen, O. E. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15392 · Cited by 12
“8 The typical applications of MR products are either as part of a comprehensive total diet replacement programme, where these products represent the sole source of nutrition, or taken one to three times daily in place of specific meals or snack, as part of a less intensive caloric restriction…”
BackgroundCho, E., Kim, S., Kim, S., Kim, J. Y., Kim, H. J., Go, Y., Lee, Y. J., Lee, H., Gil, S., Yoon, S. K., et al. (2024) · Nutrients · doi:10.3390/nu16142254 · Cited by 18
“Furthermore, they significantly reduce weight, BMI, body fat, fasting blood glucose, and HbA1c levels in patients with type 2 diabetes and obesity [28] and are effective in improving MASLD [29].”
BackgroundRafey, M. F., Abdalgwad, R., O’Shea, P. M., Foy, S., Claffey, B., Davenport, C., O'Keeffe, D. T., & Finucane, F. M. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.845574 · Cited by 14
Eurasian clinical practice guidelines for dietary management of cardiovascular diseases (2024)
Starodubova, A. V., Chazova, I. E., Tutelyan, V. A., Nikityuk, D. B., Pavlovskaya, E. V., Кislyak, O. A., Blinova, N. V., Brumberg, A. A. B., Bubnova, M. G., Varaeva, Y. R., et al. (2024) · Eurasian heart journal · doi:10.38109/2225-1685-2024-4-6-66 · Cited by 13
Noronha, J. C., Kendall, C. W. C., & Sievenpiper, J. L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.875535 · Cited by 9
Self-citationPaz‐Graniel, I., Becerra‐Tomás, N., Babió, N., Serra‐Majem, L., Vioqué, J., Zomeño, M. D., Corella, D., Pintó, X., Bueno‐Cavanillas, A., Tur, J. A., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.05.014 · Cited by 10
Self-citationThomas, S., Besecker, B. Y., Choe, Y. S., & Christofides, E. (2024) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2024.1399410 · Cited by 8
Dietary Approaches and Health Outcomes: An Evidence Analysis Center Scoping Review
Handu, D., & Piemonte, T. A. (2021) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2021.08.106 · Cited by 9
Santen, R. J., Nass, R. M., Cunningham, C., Horton, C., & Yue, W. (2022) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x221106041 · Cited by 11
Cho, E., Kim, S., Kim, H. J., Cho, B., Park, J., Kwon, H., Kim, J. Y., Go, Y., Kang, D. G., Shin, E., et al. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1370737 · Cited by 6
Was ist gesichert in der Therapie der Adipositas
Bischoff, G. (2022) · Die Innere Medizin · doi:10.1007/s00108-022-01420-x · Cited by 3
Maddahi, N. S., Sohouli, M. H., Magalhães, E. I. D. S., Ezoddin, N., & Nadjarzadeh, A. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuae206 · Cited by 3
Fotros, D., Rohani, P., Prabahar, K., Fatahi, S., Sohouli, M. H., & Guimarães, N. S. (2025) · Clinical Hypertension · doi:10.5646/ch.2025.31.e17 · Cited by 2
“In line with these findings, a separate systematic review and meta-analysis by Noronha et al. [13] revealed that the inclusion of liquid MRs in weight loss diets resulted in moderate decreases in body weight, BMI, and SBP.”
de Zwaan, M., Hauner, H., Holzapfel, C., Engeli, S., Leitlinienkoordinator*in, S. F. A. A., & Adipositas):, V. D. K. T. (. D. Z. (2025) · Adipositas - Ursachen Folgeerkrankungen Therapie · doi:10.1055/a-2552-3990 · Cited by 2
“…nach GRADE: Moderat ⊕⊕⊕⊖ (für Liquid meal replacement vs. traditional low-calorie weight loss diets für das Outcome body weight, BMI und body fat [43]); Niedrig ⊕⊕⊖⊖ (für VLEDs (very low energy diets), defined as 800 kcal day or less) + behavioural programme vs. brief intervention für das…”
Jin, J., Yu, L., Zheng, J., Xu, J., Chen, L., Liu, S., Cao, X., Hu, Y., Yan, C., & Wu, X. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02711-6 · Cited by 3
“Lifestyle changes (e.g., dietary control and exercise interventions) [49–51], pharmacological treatments (e.g., SGLT2i and GLP-1 RA [52, 53], which may be synergistic with Inclisiran [54]) and surgical procedures (e.g., bariatric surgery) [55] have demonstrated their efficacy in decreasing visceral…”
Lin, S., Deed, G., Khoo, C. L., Murfet, G. O., Barclay, A., Maberly, G., Blackie, A., Peng, W., & Andrikopoulos, S. (2026) · Diabetology · doi:10.3390/diabetology7020024 · Cited by 1
Halappa, N., Shetty, P., Dinesh, S., & Rajany, T. (2018) · Ancient Science of Life · doi:10.4103/asl.asl_1_18 · Cited by 2
Durbin, C. G., Hutchison, A., Colecchi, T., Mulligan, J., Bodepudi, S., Zanni, M. V., & Anekwe, C. V. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09925-6 · Cited by 2
“Through promoting weight loss, MR has been shown to reduce HbA1c, fasting glucose, and fasting insulin in patients with overweight or obesity and prediabetes or diabetes [43, 44].”
Zagury, R., Lacativa, P. G. S., de Gregório, L. H., Rosenfeld, V. A. S., Campos, L. F., Pinheiro, R. A. C., da Costa, S. F., & Russo, L. A. T. (2022) · Nutrición Hospitalaria · doi:10.20960/nh.04204 · Cited by 3
A comparison of virtual and in person delivery of a full meal replacement program for obesity
Skeldon, M., Harris, D., Dent, R., & Shiau, J. Y. (2023) · Obesity Science & Practice · doi:10.1002/osp4.718 · Cited by 1
Glenn, A. J., & Liu, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1094954 · Cited by 4
Hickson, K. A., Heppenstall, C., Treweeke, A. T., Coghill, E. M., Megson, I. L., Nicolson, S., Macfarlane, D. P., & MacRury, S. M. (2025) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.70128 · Cited by 1
Ernährungsempfehlungen bei Typ-2-Diabetes: Grundlegendes Umdenken
Worm, N., McKenzie, A. L., & Lechner, K. (2021) · Deutsches Ärzteblatt · doi:10.3238/persdia.2021.11.05.06 · Cited by 1
Evaluating whole fruit feijoa powder for type 2 diabetes risk prevention: the FERDINAND RCTPreprint
Mohamed, I. M. A. E.-A., Sequeira, I. R., Lim, J. J., Plank, L. D., Murphy, R., Poppitt, S. D., & Miles-Chan, J. L. (2025) · medRxiv · doi:10.1101/2025.06.18.25329000 · Cited by 1
Nutzen von Formuladiäten im Hinblick auf kardiovaskuläre Risikofaktoren
Mai, K. (2019) · Info Diabetologie · doi:10.1007/s15034-019-1568-5
Diätpulver-Drinks gegen Diabetiker-Pfunde
Mai, K. (2020) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-020-0054-2
Sievenpiper, J. L. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuaa054 · Cited by 1
Self-citationNutrition counsellors’ recommended eating patterns for individuals with type 2 diabetes in the USA
KHOSROVANEH, K. L., Hisamatsu, R., Reiss, J., RAU, J., Oshman, L. D., Diez, H. L., Lee, J. M., Aikens, J. E., Richardson, C. R., & Hafez, D. (2024) · BMJ Nutrition Prevention & Health · doi:10.1136/bmjnph-2023-000845 · Cited by 1
Hauner, H. (2024) · Springer eBooks · doi:10.1007/978-3-662-58895-6_18
Noronha, J. C., Nishi, S. K., Khan, T. A., Mejía, S. B., Kendall, C. W. C., Kahleová, H., Rahelić, D., Salas‐Salvadó, J., Leiter, L. A., Lean, M. E. J., et al. (2024) · doi:10.32920/26524456.v1
Self-citationNoronha, J. C., Nishi, S. K., Khan, T. A., Mejía, S. B., Kendall, C. W. C., Kahleová, H., Rahelić, D., Salas‐Salvadó, J., Leiter, L. A., Lean, M. E. J., et al. (2024) · doi:10.32920/26524456
Self-citationThe Frequency of Meal-Replacement Products Drinking and All-Cause, CVD, and Cancer Mortality
Zhao, Y., Li, A., Haiming, Y., Xiao, M., Song, M., Shao, Z., Jiao, R., Pang, Y., Gao, W., Huang, T., et al. (2024) · Nutrients · doi:10.3390/nu16213770
The Importance of Dietary Intervention in Obesity Management
Seo, Y. B. (2024) · Korean Journal of Family Practice · doi:10.21215/kjfp.2024.14.4.193
Mansor, W. A. N. C. W., Shahar, S., Tohit, N. M., Rajikan, R., & Ismail, M. (2025) · medRxiv · doi:10.1101/2025.01.20.25320837
“However, the study's outcome is influenced by the duration of the intervention [18–20], type of intervention [21,22], type of MR [23]and frequency of the MR given [24], which play a role in the outcome of the study.”
Kempf, K., Röhling, M., & Martin, S. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1644442 · Cited by 1
Mansor, W. A. N. C. W., Shahar, S., Tohit, N. M., Rajikan, R., & Ismail, M. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-099562
“19 20 However, the study’s outcome is influenced by the duration of the intervention, 20–22 the type of intervention, 23 24 the type of MR, 25 and frequency of the MR given, 26 which play a role in the outcome of the study.”
Khoo, C. M., Tan, M. Z.-W., Eng, S. K., Leong, C. K., Bee, Y. M., Tham, K. W., Bhaskaran, K., Lee, Y. V., Wong, G., Chan, S. L., et al. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1810277
“DSF use is endorsed by experts and clinically proven to support glycaemic control, promote quality weight loss, and improve cardio-metabolic risk factors in individuals with T2DM and overweight/ obesity (14, 26, 29–31).”
InfluentialTaiwanese consensus statement on the use of diabetes‐specific formula: Scientific evidence
Ch, C., Peng, H.-Y., Lee, C., Wang, C., Ko, Y., Chen, W., Hsu, P.-H., Huang, C., Yang, Y., Yeh, K.-M., et al. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70329
“…Glucerna (cid:2) SR, SlimFast (cid:2) , Med-ifast (cid:2) ) as part of weight-loss diets improved cardiometabolic risk factors in patients with T2D (e.g., weight, systolic BP, body fat, HbA1c, FBG, fasting insulin) better than traditional low-calorie diets, although the difference was marginal 10 .”
Jahn, S. L., Demircan, K., Chillon, T. S., Schuppelius, B., Lalama, E., Zhang, J., Hackler, J., Rüther, K. J. A., Csanalosi, M., Christ, A., et al. (2026) · Clinical Nutrition · doi:10.1016/j.clnu.2026.106693
Approaches for Individualizing the Diabetes Eating Plan
Evert, A. B. (2026) · American Diabetes Association eBooks · doi:10.2337/9781580408493-ch03
Metadata
- Authors
- Noronha, J. C., Nishi, S. K., Braunstein, C. R., Khan, T. A., Blanco Mejia, S., Kendall, C. W. C., Kahleová, H., Rahelić, D., Salas-Salvadó, J., Leiter, L. A., & Sievenpiper, J. L.
- Affiliations
- St. Michael's Hospital (CA)
- Toronto 3D (Diet, Digestive Tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael’s Hospital, Toronto, Canada
- Physicians Committee for Responsible Medicine (US)
- University of Zagreb (HR)
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, Madrid, Spain
- Corresponding author
- Sievenpiper, John L.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2019-03-28
- Volume
- 42
- Issue
- 5
- Pages
- 767-776
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2923639533
- Cited by
- 65
- References
- 38
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 15 · 2023: 6 · 2022: 9 · 2021: 6 · 2020: 6 · 2019: 5
- FWCI
- 1.00
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- DNSG
- Canadian Institutes of Health Research (129920)
- Toronto 3D
- Physicians’ Services Incorporated Foundation
- Diabetes Canada
- Banting & Best Diabetes Centre
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Keywords
- type 2 diabetes, cardiometabolic risk factors, weight loss diet, overweight and obesity, weight loss, HbA1c, fasting insulin, blood pressure, waist circumference, fat mass, serum lipids, glycemic control, dietary intervention, body composition, fasting blood glucose, systolic blood pressure, diastolic blood pressure, body mass index
- MeSH terms
- Adult, Body Weight, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Diet, Reducing, Fasting, Female, Humans, Insulin, Male, Obesity, Risk Factors, Randomized Controlled Trials as Topic, Overweight, Meals
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.